Balyasny Asset Management
LUMO

Balyasny Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Balyasny Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
2018
Q2 		$111K Buy
2018
Q1 		$73K Buy
2017
Q2 		– Sell
2017
Q1 		$4.8M Buy
2016
Q4 		– Sell
2016
Q3 		$1.18M Buy
2016
Q2 		$845K Buy
2014
Q2 		– Sell
2014
Q1 		$852K Buy